SCHEMBL21038495

SCHEMBL21038495

c1ccc(-c2ccc(-c3ccccc3N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
TSPO P30536 5/20 0.41
PTGER4 P35408 1/20 0.35
KMT2A Q03164 2/20 0.34
IL1R1 P14778 1/20 0.34
HDAC4 P56524 1/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
NPY5R Q15761 1/20 0.32
DNM1 Q05193 1/20 0.32
MAPK8 P45983 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
HSD17B10 Q99714 1/20 0.31
RAC2 P15153 1/20 0.31
RAC3 P60763 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24221811 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL20707401 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL21247452 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL21011051 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL24221792 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL24221809 0.99 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL13130911 0.99 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL24221720 0.97 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL24752375 0.97 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL15306357 0.97 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPOPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 US disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 US disclosed
EP-4242286-A2 MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2023-09-13 EP disclosed
EP-3714022-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-07 EP disclosed
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-09-24 US disclosed
WO-2019101719-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832513-B2 Materials for electronic devices PNMT, DDT, COMT L3MBTL1 3148/4885KDM4E 3302/4885ATM 1537/4885
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES PNMT, DDT, COMT L3MBTL1 3148/4885KDM4E 3302/4885ATM 1537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.